[Treatment with vitamin D metabolites for rickets/osteomalacia]. 2003

Yasuhiro Takeuchi
Division of Endocrinology and Nephrology, Department of Medicine, University of Tokyo School of Medicine.

Rickets and osteomalacia is a metabolic bone disease due to a mineralization defect as principal pathophysiology. Since a variety of disorders cause insufficient mineralization of bone, treatment specific to each disorder should be applied to a patient with rickets/osteomalacia. Clinical consensus for medical treatment for rickets/osteomalacia is overviewed in this manuscript. Vitamin D as an anti-rachitic factor and its metabolites play a pivotal role for treatment of patients with rickets/osteomaracia.

UI MeSH Term Description Entries

Related Publications

Yasuhiro Takeuchi
January 2018, Clinical calcium,
Yasuhiro Takeuchi
January 2018, Clinical calcium,
Yasuhiro Takeuchi
October 1984, The Orthopedic clinics of North America,
Yasuhiro Takeuchi
June 1977, Health visitor,
Yasuhiro Takeuchi
September 2002, Seminars in musculoskeletal radiology,
Yasuhiro Takeuchi
November 1972, The Orthopedic clinics of North America,
Yasuhiro Takeuchi
August 1977, Archives of disease in childhood,
Yasuhiro Takeuchi
April 1995, Revue du rhumatisme (English ed.),
Yasuhiro Takeuchi
January 2018, Clinical calcium,
Yasuhiro Takeuchi
January 2018, Clinical calcium,
Copied contents to your clipboard!